Variables | Adjusted OR | 95% CI | p Value |
---|---|---|---|
Admission data | |||
SAPS II > 50 | 4.21 | 2.35-7.56 | < 0.0001 |
Vasoactive drugs within 48 hrs of admission | 2.91 | 1.51-5.61 | 0.0001 |
PSI class V | 2.70 | 1.3- 5.6 | 0.007 |
Historical period | 2.53 | 1.42-4.52 | 0.001 |
Therapeutics interventions | |||
Epinephrine use | 4.97 | 1.96-12.6 | 0.0007 |
Low-dose steroid administration | 2.29 | 1.18-4.46 | 0.01 |
Dobutamine | 2.12 | 1.09-4.11 | 0.02 |
Transfusion | 1.92 | 1.07-3.44 | 0.02 |
Combination of a 3rdGC and levofloxacin | 0.37 | 0.19-0.74 | 0.004 |
Systematic postextubation NIMV | 0.30 | 0.11-0.82 | 0.01 |
Whole data | |||
SAPS II > 50 | 3.51 | 1.89-6.51 | < 0.0001 |
PSI risk class V | 2.73 | 1.23-6.04 | 0.01 |
Vasoactive drugs within 48 hrs of admission | 2.48 | 1.21-5.08 | 0.01 |
Transfusion | 1.97 | 1.06-3.65 | 0.03 |
Combination of a 3rdGC and levofloxacin | 0.36 | 0.18-6.51 | 0.002 |
Systematic postextubation NIMV | 0.34 | 0.12-0.95 | 0.03 |